B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Dolutegravir

298 PubMed studies analyzed ยท 51 RCTs ยท Evidence Score: 50.1

Research Domains

Dolutegravir has been studied across 12 research domains including ๐Ÿ”ฅ Metabolic, ๐Ÿ˜ด Sleep, ๐Ÿง  Focus & Attention, ๐Ÿซ Liver & Detox, ๐Ÿซ˜ Kidney. The primary research focus is ๐Ÿ”ฅ Metabolic with 4% of studies addressing this area.

Loading evidence profile...

This evidence profile for Dolutegravir is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.